EMEA-001428-PIP01-13
Key facts
Active substance |
Esketamine
|
Therapeutic area |
Psychiatry
|
Decision number |
P/0177/2013
|
PIP number |
EMEA-001428-PIP01-13
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of major depressive disorder
|
Route(s) of administration |
Intranasal use
|
Contact for public enquiries |
Janssen-Cilag International N.V.
E-mail: mojanen@ITS.JNJ.com |
Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|